Relmada Therapeutics
RLMD
#8615
Rank
NZ$0.16 B
Marketcap
$5.45
Share price
2.74%
Change (1 day)
8.85%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: NZ$0.16 Billion

As of September 2024 Relmada Therapeutics has a market cap of NZ$0.16 Billion. This makes Relmada Therapeutics the world's 8615th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$0.16 B-16.59%
2023NZ$0.19 B19.09%
2022NZ$0.16 B-81.87%
2021NZ$0.91 B25.3%
2020NZ$0.72 B-12.86%
2019NZ$0.83 B1538.71%
2018NZ$51 M285.04%
2017NZ$13.24 M-30.05%
2016NZ$18.93 M-56.84%
2015NZ$43.87 M-79.32%
2014NZ$0.21 B

End of Day market cap according to different sources

On Sep 29th, 2024 the market cap of Relmada Therapeutics was reported to be:

NZ$0.16 Billion
by Yahoo Finance info icon info icon
NZ$0.16 Billion
by CompaniesMarketCap info icon info icon
NZ$0.16 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$2.61 B 1,488.22%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$9.95 B 5,956.15%๐Ÿ‡บ๐Ÿ‡ธ USA